Sort
16,300 grants matching “fatty liver disease”
Long noncoding RNAs regulating liver fibrosis
$378,000Alan C Mullen · Massachusetts General Hospital · R01 · FY2020 · DK
Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins
$378,000Rajat Singh · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Long noncoding RNAs regulating liver fibrosis
$378,000Alan C Mullen · Massachusetts General Hospital · R01 · FY2021 · DK
Role of CMA failure in NASH progression to Hepatocellular Carcinoma
$378,000Esperanza Arias-Perez · Albert Einstein College Of Medicine · R01 · FY2023 · DK
Long noncoding RNAs regulating liver fibrosis
$378,000Alan C Mullen · Massachusetts General Hospital · R01 · FY2019 · DK
Role of CMA failure in NASH progression to Hepatocellular Carcinoma
$378,000Esperanza Arias-Perez · Albert Einstein College Of Medicine · R01 · FY2022 · DK
Role of CMA failure in NASH progression to Hepatocellular Carcinoma
$378,000Esperanza Arias-Perez · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins
$378,000Rajat Singh · Albert Einstein College Of Medicine · R01 · FY2022 · DK
The therapeutic effect of cannabigerol (CBG) with or without cannabidiol (CBD) in diet-induced non-alcoholic fatty liver disease
$377,986Yuyan Han · University Of Northern Colorado · R15 · FY2024 · DK
New infection-related proteins of Plasmodium sporozoites and liver stages
$377,927Stefan H.i. Kappe · Seattle Biomedical Research Institute · R01 · FY2011 · AI
New infection-related proteins of Plasmodium sporozoites and liver stages
$377,927Stefan H.i. Kappe · Seattle Biomedical Research Institute · R01 · FY2012 · AI
Mechanisms of Regulation of Retinoic Acid Homeostasis
$377,912Nina Isoherranen · University Of Washington · R01 · FY2021 · GM
"Mount Sinai Regional Drug Induced Liver Injury Network Site"
$377,804Joseph Odin · Icahn School Of Medicine At Mount Sinai · U01 · FY2017 · DK
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia
$377,780Aaron Grossberg · Oregon Health & Science University · R37 · FY2025 · CA
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
$377,754Sonia Caprio · Yale University · R01 · FY2010 · HD
Molecular mechanisms of fatty liver disease: role of the protein DBC1
$377,750Eduardo N Chini · Mayo Clinic Rochester · R01 · FY2009 · DK
Microbiome, metabolites, and alcohol in HIV to reduce CVD Cohort (META HIV CVD Cohort)
$377,630Kaku So-Armah · Vanderbilt University Medical Center · P01 · FY2023 · AA
Molecular regulation of gut lipid metabolism by mTOR and autophagy proteins
$377,625Rajat Singh · Albert Einstein College Of Medicine · R01 · FY2020 · DK
Divergence in Aerobic Capacity Drives Liver and Brain Health
$377,622John P Thyfault · University Of Kansas Medical Center · R01 · FY2021 · DK
Signaling-pathway-based preventative strategies for alcoholic liver disease
$377,516Albert J Fornace · Georgetown University · R01 · FY2013 · AA
Effect of Insulin and Propranolol on Post Burn Hypermetabolism and Inflammation
$377,500David N Herndon · University Of Texas Med Br Galveston · R01 · FY2009 · GM
Effect of Insulin and Propranolol on Post Burn Hypermetabolism and Inflammation
$377,500David N Herndon · University Of Texas Med Br Galveston · R01 · FY2008 · GM
HEME Protein Reductases
$377,451Stephen G. Sligar · University Of Illinois At Urbana-Champaign · R01 · FY2011 · GM
HEME Protein Reductases
$377,451Stephen G. Sligar · University Of Illinois At Urbana-Champaign · R01 · FY2012 · GM
Cleavage Products of Dietary Carotenoids: Occurrence & Nutritional Function
$377,438Earl Howard Harrison · Ohio State University · R01 · FY2012 · HL